Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07209202
NA

Fructose Intestinal Gluconeogenesis

Sponsor: Touro University, California

View on ClinicalTrials.gov

Summary

This study will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. We will investigate whether this protective effect of the intestine is impaired in individuals with obesity.

Official title: Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals With Obesity

Key Details

Gender

All

Age Range

20 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-03-02

Completion Date

2030-06

Last Updated

2026-03-06

Healthy Volunteers

Yes

Interventions

OTHER

High fructose meal

Liquid meals containing 55% total carbohydrate (16% fructose), 30% fat, 15% protein.

OTHER

Low fructose meal

55% total carbohydrate (6% fructose), 30% fat, 15% protein.

OTHER

13C labeled fructose, oral

Tracer amount of 13C labeled fructose administered orally in the meals.

OTHER

13C labeled fructose, intravenous

Tracer amount of 13C fructose administered intravenously

Locations (1)

Touro University California

Vallejo, California, United States